Bill · H.R. 4019· House(119-HR-4019)
Gio’s Law
- Introduced
- 6/17/2025
- Last activity
- 6/17/2025 — Referred to the House Committee on the Judiciary.
- Sponsored by
- Laura Gillen
- Cosponsors
- - 3 - 6
- Introduced
- In Committee
What this bill would do
This bill, known as "Gio's Law," seeks to amend the Omnibus Crime Control and Safe Streets Act of 1968. It establishes a grant program to provide law enforcement officers with access to and training on epinephrine products. The Attorney General is authorized to grant funds to States and local government units for purchasing products and training officers. Training will focus on recognizing anaphylactic reaction symptoms and correctly administering epinephrine. To receive a grant, a State must certify that officers are protected from civil liability when administering these products. Finally, the bill mandates annual data reporting and a public awareness campaign.
Yes· 3 of 5
Would Native Americans be better off under this?+5
The bill specifically includes tribal law enforcement agencies in the grant eligibility.
Does this make health care easier to get in general?+5
The bill enhances access to life-saving emergency care through law enforcement intervention.
Does this make what the government does easier for the public to see?+4
The bill mandates annual data reporting on epinephrine administration to be made publicly available.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Access to Life-Saving Medication: The bill allows for the purchase of epinephrine products, such as auto-ejectors, for use by State, local, and tribal law enforcement agencies (Section 3061).
-
Officer Training: Law enforcement officers will receive training to recognize the symptoms of an anaphylactic reaction and correctly administer epinephrine products (Section 3062).
-
Public Education: The Attorney General, working with the Secretary of Health and Human Services, will implement a campaign to educate the public on anaphylactic symptoms and the role of law enforcement in administering epinephrine (Section 4).
-
Transparency: The Attorney General must submit and make publicly available annual data regarding how often law enforcement officers administer epinephrine products (Section 3).
Potential Negative Impacts for People
- Liability Requirements: For a State or local government to receive a grant, the State attorney general must certify that law enforcement officers are protected from civil liability when administering epinephrine to an individual (Section 3063).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Governance And Ideology
- Improves Government Transparency+4Increases Federal Power+2
- Demographic And Interest Groups
- Good For Native Americans+5
- Healthcare
- Improves Healthcare Access+5
- Social Issues And Justice
- Improves Policing Reform+3
- 5/29/2026
- 2 Cosponsors added.
- 5/22/2026
- 1 Cosponsor added.
- 2/20/2026
- 1 Cosponsor added.
- 1/27/2026
- 1 Cosponsor added.
- 10/28/2025
- 1 Cosponsor added.
- 9/26/2025
- 1 Cosponsor added.
- 7/2/2025
- 1 Cosponsor added.
- 6/17/2025
- Referred to the House Committee on the Judiciary.
- 1 Cosponsor added.
- Introduced in House
Brian FitzpatrickRepublican · Pennsylvania
Scott FitzgeraldRepublican · Wisconsin
Andrew GarbarinoRepublican · New York
Jennifer KiggansRepublican · Virginia
Michael LawlerRepublican · New York
Eleanor NortonDemocrat · District of Columbia
Zachary NunnRepublican · Iowa
Deborah RossDemocrat · North Carolina
James WalkinshawDemocrat · Virginia